SCHEMBL7044593

SCHEMBL7044593

COC(=O)COc1ccc(O)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.54
LMNA P02545 1/20 0.53
LPAR2 Q9HBW0 1/20 0.47
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 3/20 0.47
HSD17B10 Q99714 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
MCL1 Q07820 1/20 0.46
HPGD P15428 1/20 0.46
PDK2 Q15119 2/20 0.45
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30087171 0.87 LMNA (0.60) PTGS2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL11528338 0.85 NPC1 (0.49) LMNAALDH1A1KMT2AMEN1MCL1
SCHEMBL7486777 0.84 HPGD (0.56) LMNAALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL2354770 0.83 PTGS2 (0.52) PTGS2LMNALPAR2ALDH1A1KDM4E
SCHEMBL5522283 0.82 ALDH1A1 (0.55) PTGS2ALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL13116437 0.81 LMNA (0.57) PTGS2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL7682886 0.80 PTGS2 (0.54) PTGS2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL21618362 0.79 ATF4 (0.53) PTGS2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL534024 0.79 PTGS2 (0.52) PTGS2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL16898011 0.79 CA12 (0.56) PTGS2LMNAALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed